PITCH
YOUR COLLABORATION
OFFER
Life Science Open Space is a community-driven event, co-created by people and organisations who want to turn life science ideas into real-world impact.
We invite researchers, startup founders, project managers, clinicians and innovators to present not only their technologies or projects, but also a clear offer for collaboration. LSOS is the right place to present a solution, define a challenge, find validation partners, build a consortium, identify pilot sites, explore funding, or open the path to market.
We invite pitches for innovative projects, prototypes, pilots, and clearly defined collaboration needs across the following sessions: Predict & Prevent, Discover & Treat, Connect & Care, Science to Business, and Startups.
Pitches may be presented as: Open Innovation, Pre-commercial Technology Offer, Project Calls & Collaboration, Project Results, Challenge, or Toolbox solutions supporting R&D and innovation.
Choose your track
Day 1
Theme 1
01
Predict & Prevent
Predict & Prevent is dedicated to innovations that help identify risk earlier and enable timely action before disease progresses. It brings together prevention, early diagnostics and personalised risk assessment with tools that support healthier living, screening and earlier intervention.
This session is for projects that want to move from promising results to clinical validation, preventive pilots, public health implementation or first commercial partnerships.
Scope
- Early diagnostics, screening tools, biomarkers, risk modelling and decision-support solutions
- Population-wide and personalised prevention strategies
- Functional food, nutrition and healthy ageing solutions
- Digital tools for lifestyle change, coaching, adherence and self-management
- Community-based prevention, workplace health and city-health initiatives
- VHP applications supporting risk stratification, disease progression modelling, screening design and validation of preventive interventions
Projects in this session should seek partners who can help validate, test, and implement their innovation: hospitals, primary care providers, diagnostic labs, public health institutions, municipalities, employers, insurers, cohort owners, data partners, and early investors.
Strong pitches will show how collaboration can transform a concept or pilot into a deployable prevention or diagnostics solution.
Predict & Prevent
Theme 2
02
Discover & Treat
Discover & Treat focuses on translating scientific discovery into therapies, therapeutic platforms and enabling medical technologies. It is the place for projects moving from research results toward preclinical, clinical, regulatory and manufacturing readiness.
We especially invite innovators looking for co-development, translational validation, licensing opportunities, industrial partnerships or scale-up support that can accelerate the path from lab to life.
Scope
- Biotech and drug development platforms
- Innovative therapies and enabling medical technologies
- AI-powered discovery, omics integration and personalised treatment design
- VHP, digital human twins and in-silico models for target validation, response prediction, trial design and treatment optimisation
- Ethics, standards, regulatory readiness and evidence-generation strategies
- Sustainable biotechnologies, biomanufacturing and bioeconomy solutions that improve resilience and scalability of therapeutic innovation
Projects in this session should use the pitch to find partners who can help de-risk and advance development: biotech, pharma and medtech companies, hospitals, translational research centres, CROs/CDMOs, manufacturing partners, TTOs, regulatory experts, investors and EU project consortia.
The strongest pitches will clearly define what is needed next: proof-of-concept support, IP strategy, preclinical validation, GMP scale-up, clinical collaboration or market-entry preparation.
Discover
& Treat
Theme 3
03
Connect & Care
Connect & Care is about innovations that improve access, adoption and value in real healthcare settings. It brings together digital health, healthtech and medical devices that can support more resilient, patient-centred and efficient care pathways.
The emphasis is on implementation and market uptake: solutions that can be integrated into workflows, tested with users and developed further with providers, payers, patient groups and public partners.
Scope
- Digital health platforms, telemedicine, home diagnostics and remote monitoring
- Medical devices and connected technologies supporting diagnosis, treatment or follow-up in distributed care models
- AI triage, decision support, workflow optimisation and interoperability solutions
- Patient engagement, adherence, rehabilitation and value-based care tools
- Public-private models that improve access to care and support system transformation
- VHP applications for personalised care planning, simulation of patient pathways, device optimisation, training and outcome prediction in routine practice
Projects in this session should look for partners who can help pilot, integrate, procure and scale their solutions: hospitals, outpatient clinics, home-care providers, patient organisations, health authorities, payers, software integrators, distributors and internationalisation partners.
Good pitches will show how collaboration can turn a digital or device-based innovation into a reimbursable, implementable and scalable healthcare solution.
Connect
& Care
Virtual Human Patient
as a cross-cutting enabler
The Virtual Human Patient, including digital twins, in-silico models and simulation-based approaches, should be treated as a cross-cutting enabler, not a separate silo.
Projects using VHP to improve prediction, de-risk development, personalise treatment, optimise devices or redesign care pathways are welcome in all three sessions. Inventors should place their pitch in the session that best reflects the project’s main route to impact and market adoption.
Day 2
Theme 4
04
Science to Business
Pitches
Science to Business Pitches are dedicated to research teams and innovation projects that are ready to move beyond scientific excellence and explore their next path toward application, partnership and market relevance. This session focuses on the transition from research results, prototypes, platform technologies and project outcomes to validation, licensing, spin-out creation, industrial collaboration or further translational development.
It is the right place for teams that have generated promising knowledge, technology or data and now need to test its value with potential users, partners, investors or implementation environments. The emphasis is not only on what has been discovered, but on what can happen next — and with whom.
Scope
- Research results with application or commercialisation potential
- Platform technologies, prototypes, methods, tools and enabling solutions
- University and institute-based innovation ready for validation or further development
- Technologies seeking licensing, spin-out support or industrial co-development
- Project results looking for continuation, uptake or consortium-building
- Proof-of-concept projects requiring business, clinical, regulatory or market validation
- AI, data-driven and digital health solutions emerging from research environments
- Life science technologies needing IP, regulatory, funding or business model support
Projects in this session should use the pitch to find partners who can help translate research into practical value: companies, investors, technology transfer offices, incubators, accelerators, hospitals, CROs/CDMOs, regulatory experts, public and European funding partners, business developers and future consortium members.
Strong pitches will clearly explain the problem addressed, the value of the research result, its current development stage and the next step needed to move toward application. The best presentations will show not only scientific quality, but also openness to collaboration, awareness of market or user needs, and a credible route from research to partnership.
Science to Business
Pitches
Theme 5
05
Startup Pitches
Startup Pitches are designed for life science ventures that are ready to present their solution, business potential and growth needs to investors, industry partners and the wider innovation ecosystem. This session focuses on startups that want to validate their market direction, gain visibility, attract financing, build strategic partnerships or prepare for scale.
It is the place for companies developing products, services, technologies or platforms with a clear route toward users, customers, payers or industrial adoption. We especially invite startups that can show not only innovation, but also traction, business readiness and a concrete need for partners who can help accelerate development.
Scope
- Life science, biotech, medtech, healthtech and digital health startups
- AI-driven health ventures with a clear business proposition
- Medical devices, diagnostics, remote monitoring and connected care solutions
- Therapeutic, biotech, platform and enabling technology companies
- Startups seeking seed, venture, corporate or strategic investment
- Ventures looking for pilot sites, clinical validation, distribution or market-entry partners
- Companies preparing for internationalisation, reimbursement, procurement or scale-up
- Teams looking for feedback on business model, go-to-market strategy or investor readiness
Startups in this session should use the pitch to connect with partners who can support the next phase of growth: investors, business angels, venture funds, corporate partners, hospitals, industry leaders, distributors, accelerators, mentors, public funding organisations and international market-entry partners.
Strong pitches will show a clear problem-solution fit, defined target market, business model, competitive advantage, development stage, traction and the specific opportunity being offered to partners or investors. The most compelling startups will demonstrate why now is the right moment to engage — and what kind of collaboration, funding or strategic support can help them move faster.
Startup Pitches
What we want hear
We encourage applicants to pitch not only a technology, research result, project or venture, but also a clear collaboration goal.
At LSOS, the projects with the greatest momentum will be those that combine innovative approach with openness to collaboration and a credible path toward implementation, partnership, market entry or further growth.
Submit your abstract and become part of Life Science Open Space 2026. Show what you are developing, what kind of collaboration you are looking for, and how your idea can contribute to the future of life science innovation. Selected speakers will have the opportunity to present their work to a community of potential partners, investors, experts and implementers ready to move ideas forward.
SUBMIT YOUR PROJECT
/ PITCH ABSTRACT
Open Innovation / Pre-commercial Technology Offer /Project Calls / Results / Challenge / Toolbox solutions
COLLABORATION
Joanna
CONTACT US
Life Science Open Space 2026 is organised as part of the project “Promotion of the Małopolska BIOregion 3 (ProBio3)”, co-financed by the European Regional Development Fund under the European Funds for Małopolska 2021–2027 programme, Priority 1: European Funds for Research, Development and Entrepreneurship, Measure 1.15: Internationalisation of the Małopolska Economy.
The ProBio3 project is carried out under the coordination of the Business in Małopolska Centre.
